Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Oct;60(4):549–554. doi: 10.1038/bjc.1989.311

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

R B Pedley 1, J A Boden 1, R W Boden 1, A Green 1, G M Boxer 1, K D Bagshawe 1
PMCID: PMC2247110  PMID: 2803924

Abstract

A human pancreatic adenocarcinoma was used to develop two histologically distinct xenograft lines, one associated with high levels (180-2000 ng ml-1) and one with low levels (greater than 2.0 less than 8.0 ng ml-1) of serum carcinoembryonic antigen (CEA). A strong correlation was found between tumour size and both circulating and tumour CEA levels in the former group, and also correlation at the 5% level between tumour size and serum CEA in the latter. Administration of either monoclonal or polyclonal 125I-anti-CEA antibody led to the formation of intravascular antigen-antibody immune complexes in mice with high CEA levels, and these were rapidly cleared by the liver, deiodination commencing within the first hour. Blood activity was reduced to 20% of the injected dose by 15 min, and by 24 h the radioactivity in all tissues except muscle was significantly below that found in either the low CEA group or in mice without tumours. No difference in radio-antibody clearance pattern was found between mice without tumours and the group with low levels of serum CEA. In spite of higher levels of CEA within the tumour in mice with elevated serum CEA, the rapid clearance of antigen-antibody complexes reduced tumour localisation to one quarter of that seen in mice with low serum, and correspondingly low tumour, CEA levels. Gamma-camera imaging confirmed these results. Possible implications to patient selection and treatment are discussed.

Full text

PDF
549

Images in this article

550Figure 1
on p.550
551Figure 4
on p.551
551Figure 5
on p.551
552Figure 7
on p.552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshawe K. D. Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here? Br J Cancer. 1983 Aug;48(2):167–175. doi: 10.1038/bjc.1983.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  4. Goldenberg D. M., Kim E. E., DeLand F. H., Bennett S., Primus F. J. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res. 1980 Aug;40(8 Pt 2):2984–2992. [PubMed] [Google Scholar]
  5. Goldenberg D. M., Preston D. F., Primus F. J., Hansen H. J. Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res. 1974 Jan;34(1):1–9. [PubMed] [Google Scholar]
  6. Goldenberg D. M., Sharkey R. M., Ford E. Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies. J Nucl Med. 1987 Oct;28(10):1604–1610. [PubMed] [Google Scholar]
  7. Hagan P. L., Halpern S. E., Chen A., Krishnan L., Frincke J., Bartholomew R. M., David G. S., Carlo D. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. J Nucl Med. 1985 Dec;26(12):1418–1423. [PubMed] [Google Scholar]
  8. Kardana A., Taylor M. E., Southall P. J., Boxer G. M., Rowan A. J., Bagshawe K. D. Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues. Br J Cancer. 1988 Sep;58(3):281–286. doi: 10.1038/bjc.1988.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Keep P. A., Searle F., Begent R. H., Barratt G. M., Boden J., Bagshawe K. D., Ryman B. E. Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodies. Oncodev Biol Med. 1983;4(4):273–280. [PubMed] [Google Scholar]
  10. Lewis J. C., Smith P. A., Keep P. A., Boxer G. M. A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts. Exp Pathol. 1983;24(4):227–235. doi: 10.1016/s0232-1513(83)80010-3. [DOI] [PubMed] [Google Scholar]
  11. Mach J. P., Carrel S., Merenda C., Sordat B., Cerottini J. C. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature. 1974 Apr 19;248(5450):704–706. doi: 10.1038/248704a0. [DOI] [PubMed] [Google Scholar]
  12. Martin K. W., Halpern S. E. Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res. 1984 Dec;44(12 Pt 1):5475–5481. [PubMed] [Google Scholar]
  13. Pedley R. B., Boden J., Keep P. A., Harwood P. J., Green A. J., Rogers G. T. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur J Nucl Med. 1987;13(4):197–202. doi: 10.1007/BF00256491. [DOI] [PubMed] [Google Scholar]
  14. Primus F. J., Bennett S. J., Kim E. E., DeLand F. H., Zahn M. C., Goldenberg D. M. Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res. 1980 Mar;40(3):497–501. [PubMed] [Google Scholar]
  15. Primus F. J., Wang R. H., Cohen E., Hansen H. J., Goldenberg D. M. Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors. Cancer Res. 1976 Jul;36(7 Pt 1):2176–2181. [PubMed] [Google Scholar]
  16. Shuster J., Silverman M., Gold P. Metabolism of human carcinoembryonic antigen in xenogeneic animals. Cancer Res. 1973 Jan;33(1):65–68. [PubMed] [Google Scholar]
  17. Thornburg R. W., Day J. F., Baynes J. W., Thorpe S. R. Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes. J Biol Chem. 1980 Jul 25;255(14):6820–6825. [PubMed] [Google Scholar]
  18. Zamcheck N., Doos W. G., Prudente R., Lurie B. B., Gottlieb L. S. Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. Hum Pathol. 1975 Jan;6(1):31–45. doi: 10.1016/s0046-8177(75)80108-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES